HRP20171166T1 - Postupak za pripravu intermedijera pirimidina - Google Patents

Postupak za pripravu intermedijera pirimidina Download PDF

Info

Publication number
HRP20171166T1
HRP20171166T1 HRP20171166TT HRP20171166T HRP20171166T1 HR P20171166 T1 HRP20171166 T1 HR P20171166T1 HR P20171166T T HRP20171166T T HR P20171166TT HR P20171166 T HRP20171166 T HR P20171166T HR P20171166 T1 HRP20171166 T1 HR P20171166T1
Authority
HR
Croatia
Prior art keywords
compound
formula
ethylene glycol
reaction
mixture
Prior art date
Application number
HRP20171166TT
Other languages
English (en)
Inventor
Stefan Abele
Jacques-Alexis Funel
Ivan SCHINDELHOLZ
Original Assignee
Actelion Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd. filed Critical Actelion Pharmaceuticals Ltd.
Publication of HRP20171166T1 publication Critical patent/HRP20171166T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Detergent Compositions (AREA)
  • Magnetic Heads (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Cores, Coils, And Magnets (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Claims (15)

1. Postupak za proizvodnju spoja sljedeće formule I-2: [image] I-2 pri čemu navedeni postupak obuhvaća reakciju spoja sljedeće formule I1: [image] I-1 gdje G1 predstavlja halogen, ili soli navedenog spoja, s etilen-glikolom u prisutnosti lužine, naznačen time, da se nakon što se dobije spoj formule I2, provodi ekstrakcija tekućina-tekućina, te se pritom upotrebljava metil-izobutil-keton za ekstrakciju spoja formule I2 iz vodene faze koja sadrži produkte reakcije spoja formule I1 s etilen-glikolom.
2. Postupak prema zahtjevu 1, naznačen time, da je spoj formule I-1 takav, da G1 predstavlja klor.
3. Postupak prema zahtjevu 1 ili 2, naznačen time, da lužina je kalijev tert-butilat.
4. Postupak prema bilo kojem od zahtjeva 1 do 3, naznačen time, da se upotrebljava od 20 do 50 ekvivalenata od etilen-glikola po ekvivalentu spoja formule I-1.
5. Postupak prema bilo kojem od zahtjeva 1 do 4, naznačen time, da pH-vrijednost vodene faze iz koje se ekstrahira spoj formule I2, iznosi od 3 do 5.
6. Postupak prema bilo kojem od zahtjeva 1 do 5, naznačen time, da se reakcija spoja formule I1 s etilen-glikolom izvodi u metil-izobutil-ketonu.
7. Postupak prema zahtjevu 6, naznačen time, da volumen metil-izobutil-ketona koji se koristi za izvođenje reakcije spoja formule I1 s etilen-glikolom, iznosi od 3 do 7 puta vrijednosti volumena etilen-glikola.
8. Postupak prema zahtjevu 6 ili 7, naznačen time, da se upotrebljava od 5 do 20 ekvivalenata etilen-glikola po ekvivalentu spoja formule I-1.
9. Postupak prema bilo kojem od zahtjeva 1 do 8, naznačen time, da se mješavina vodene faze i organske faze zagrijava na temperaturu od 35 do 60°C, prije nego što se faze razdvoje.
10. Postupak prema bilo kojem od zahtjeva 1 do 9, naznačen time, da se spoj formule I2 koji se dobiva nakon reakcije spoja formule I1 s etilen-glikolom i ekstrakcije tekućina-tekućina, kristalizira pomoću djelomične evaporacije metil-izobutil-ketona iz sakupljene organske faze, pri čemu se dodaje nepolarno aprotonsko organsko otapalo ili smjesa nepolarnih aprotonskih organskih otapala u navedenu organsku fazu, a tako dobivena smjesa se zagrijava sve dok se ne dobije potpuno kruta otopina, te se potom smjesa rashlađuje kako bi se dobila kristalizacija spoja formule I2.
11. Postupak prema zahtjevu 10, naznačen time, da se spoj formule I2 koji se dobiva nakon reakcije spoja formule I1 s etilen-glikolom i ekstrakcije tekućina-tekućina, kristalizira pomoću djelomične evaporacije metil-izobutil-ketona iz sakupljene organske faze, zatim se dodaje heptan u navedenu organsku fazu, a tako dobivena smjesa se zagrijava sve dok se ne dobije potpuno kruta otopina, te se potom smjesa rashlađuje kako bi se dobila kristalizacija spoja formule I2.
12. Postupak prema bilo kojem od zahtjeva 1 do 11, naznačen time, da udio ostatka etilen-glikola u dobivenom spoju formule I2, iznosi ispod 500 ppm.
13. Uporaba metil-izo-butil-ketona, naznačena time, da je za odstranjivanje etilen-glikola iz spoja formule I2 kako je definirano u zahtjevu 1, kada se navedeni spoj dobiva pomoću reakcije spoja formule I1 s etilen-glikolom u prisutnosti lužine, kako je definirano u zahtjevu 1.
14. Uporaba metil-izo-butil-ketona, naznačena time, da je za odstranjivanje etilen-glikola iz spoja formule I2 kako je definirano u zahtjevu 1, kada se navedeni spoj dobiva pomoću reakcije spoja formule I1 s etilen-glikolom u prisutnosti lužine, kako je definirano u zahtjevu 2.
15. Uporaba prema zahtjevu 13 ili 14, naznačena time, da udio ostatka etilen-glikola u spoju formule I2 koji se dobiva nakon navedene uporabe, iznosi ispod 500 ppm.
HRP20171166TT 2013-07-12 2017-07-31 Postupak za pripravu intermedijera pirimidina HRP20171166T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13176374 2013-07-12
EP14737272.6A EP3019479B1 (en) 2013-07-12 2014-07-11 Process for preparing a pyrimidine intermediate
PCT/EP2014/064904 WO2015004265A1 (en) 2013-07-12 2014-07-11 Process for preparing a pyrimidine intermediate

Publications (1)

Publication Number Publication Date
HRP20171166T1 true HRP20171166T1 (hr) 2017-10-06

Family

ID=48790244

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20171166TT HRP20171166T1 (hr) 2013-07-12 2017-07-31 Postupak za pripravu intermedijera pirimidina

Country Status (17)

Country Link
US (1) US9556125B2 (hr)
EP (1) EP3019479B1 (hr)
JP (1) JP6375374B2 (hr)
KR (1) KR102305298B1 (hr)
CN (1) CN105636940B (hr)
AR (1) AR096865A1 (hr)
CA (1) CA2915736C (hr)
DK (1) DK3019479T3 (hr)
ES (1) ES2636937T3 (hr)
HR (1) HRP20171166T1 (hr)
HU (1) HUE034071T2 (hr)
IL (1) IL243477B (hr)
MX (1) MX360768B (hr)
PL (1) PL3019479T3 (hr)
PT (1) PT3019479T (hr)
TW (1) TWI643848B (hr)
WO (1) WO2015004265A1 (hr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA201605808B (en) 2015-08-26 2017-08-30 Cipla Ltd Process for preparing an endothelin receptor antagonist
CN105461638A (zh) * 2015-12-10 2016-04-06 合肥久诺医药科技有限公司 一种马西替坦晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094781B2 (en) * 2000-12-18 2006-08-22 Actelion Pharmaceuticals Ltd. Sulfamides and their use as endothelin receptor antagonists
CN103724281A (zh) * 2013-12-03 2014-04-16 镇江圣安医药有限公司 N-[5-(4-溴苯基)-6-[2-[(5-溴-2-嘧啶基)氧基]乙氧基]-4-嘧啶基]-n′-丙基磺酰胺的新型衍生物及其应用
CN103819411A (zh) * 2014-03-14 2014-05-28 成都克莱蒙医药科技有限公司 一种马西替坦中间体新的制备方法

Also Published As

Publication number Publication date
MX360768B (es) 2018-11-15
KR102305298B1 (ko) 2021-09-27
CA2915736C (en) 2021-07-27
JP6375374B2 (ja) 2018-08-15
AR096865A1 (es) 2016-02-03
EP3019479B1 (en) 2017-05-10
US20160145215A1 (en) 2016-05-26
MX2016000386A (es) 2016-04-29
EP3019479A1 (en) 2016-05-18
JP2016525094A (ja) 2016-08-22
PT3019479T (pt) 2017-08-11
US9556125B2 (en) 2017-01-31
PL3019479T3 (pl) 2017-10-31
HUE034071T2 (en) 2018-01-29
KR20160030972A (ko) 2016-03-21
TW201536759A (zh) 2015-10-01
CN105636940A (zh) 2016-06-01
CA2915736A1 (en) 2015-01-15
IL243477B (en) 2018-06-28
TWI643848B (zh) 2018-12-11
WO2015004265A1 (en) 2015-01-15
DK3019479T3 (en) 2017-07-17
ES2636937T3 (es) 2017-10-10
CN105636940B (zh) 2018-02-27

Similar Documents

Publication Publication Date Title
HRP20200849T1 (hr) Postupci razdvajanja dijastereoizomera gemcitabin-fosfata
HRP20210360T1 (hr) Postupci obrade materijala koji sadrže litij
HRP20201450T1 (hr) Postupak za proizvodnju derivata pirimidin-sulfamida
HRP20171166T1 (hr) Postupak za pripravu intermedijera pirimidina
HRP20171167T1 (hr) Priprava intermedijera pirimidina koji služe za proizvodnju macitentana
RU2013109742A (ru) Способ реэкстракции редкоземельных металлов из органических растворов и получение концентрата редкоземельных металлов
MX2015011381A (es) Metodo para purificar acido ferulico y/o sales del mismo.
FI20116209A (fi) Menetelmä propionihapon talteenottamiseksi ja puhdistamiseksi
MX2018004009A (es) Proceso para la recuperacion de una mezcla que comprende un derivado de acido (tio) fosforico.
HRP20192143T1 (hr) Postupak za pripravu 1-(3,5-diklorofenil)-2,2,2-trifluoroetanona i njegovih derivata
HRP20170497T1 (hr) Postupak dobivanja nalmefen hidroklorida
PH12019500435A1 (en) Method for producing scandium compound, and scandium compound
BR112016024977A2 (pt) processo para a preparação de polimorfos de imidacloprida
JP2016525094A5 (hr)
CN101885494B (zh) 橡胶硫化促进剂生产废水中盐的纯化工艺
PL408661A1 (pl) Sposób recyklingu odpadowych materiałów termoizolacyjnych
JP2017516843A5 (hr)
LV14759A (lv) Tāss ķīmiskās pārstrādes paņēmiens un iekārta tā realizēšanai
BR112018009985B8 (pt) processo para o isolamento de um derivado de ácido
AR071546A1 (es) Proceso para recuperar florfenicol y analogos de florfenicol. metodo.
EA201590558A1 (ru) Способ экстракции растворителем
WO2013052694A3 (en) Liquid-liquid extraction process and apparatus
WO2016194003A3 (en) Separation of organic acids from mixtures containing ammonium salts of organic acids
GB201120138D0 (en) Novel process
RU2018127060A (ru) Способ получения (мет)акриловой кислоты